P08253 (MMP2_HUMAN) Homo sapiens (Human)

72 kDa type IV collagenase UniProtKBInterProSTRINGInteractive Modelling

660 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

14 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
proMMP-2/TIMP-2 complex Heteromer
P16035;
30-660
SO4;ZN;CA;
Assess
Crystal structure of MMP-2 active site mutant in complex with APP-drived decapeptide inhibitor Heteromer
P05067;
110-449
ZN;CA;
Assess
Catalytic domain of proMMP-2 E404Q mutanthomo-2-mer32-452
SO4;ZN;CA;
Assess
GELATINASE A (FULL-LENGTH)monomer31-660
ZN;CA;CL;NA;SO4;
Assess
Crystal structure of human MMP-2 catalytic domain in complex with inhibitormonomer110-450
ZN;CA;2HP;L2U;
Assess
Crystal structure of human MMP-2 catalytic domain in complex with inhibitormonomer110-450
ZN;CA;
Assess
Crystal structure of human MMP-2 catalytic domain in complex with inhibitormonomer111-450
ZN;CA;B3P;CL;
Assess
CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAINmonomer115-449
ZN;CA;
Assess
C-TERMINAL DOMAIN (HAEMOPEXIN-LIKE DOMAIN) OF HUMAN MATRIX METALLOPROTEINASE-2monomer458-660
CL;CA;
Assess
C-TERMINAL DOMAIN OF GELATINASE Amonomer461-660
ZN;CA;CL;NA;
Assess
SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020monomer110-214
ZN;CA;I52;
Assess
THE SECOND TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2monomer278-336
Assess
The Third Fibronectin Type II Module from Human Matrix Metalloproteinase 2monomer337-394
Assess
The First Fibronectin Type II Module from Human Matrix Metalloproteinase 2monomer223-278
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1ck7.1.Amonomer0.8331-660
ZN;CA;99.84
Assess
3ba0.1.Amonomer0.51116-660
ZN;CA;HAE;44.35
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21ck7.1.Amonomer0.831-584
ZN;CA;99.83
Assess
Isoform 23ba0.1.Amonomer0.5240-584
ZN;CA;HAE;44.35
Assess
Isoform 31ck7.1.Amonomer0.831-610
ZN;CA;99.67
Assess
Isoform 33ba0.1.Amonomer0.5166-610
ZN;CA;HAE;44.35
Assess